Cutler Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4K | Sell |
300
-200
| -40% | -$2.67K | ﹤0.01% | 743 |
|
|
2023
Q4 | $8K | Sell |
500
-100
| -17% | -$1.6K | ﹤0.01% | 1037 |
|
|
2023
Q3 | $7K | Hold |
600
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q2 | $8K | Hold |
600
| – | – | ﹤0.01% | 1036 |
|
|
2023
Q1 | $9K | Sell |
600
-200
| -25% | -$3K | ﹤0.01% | 1026 |
|
|
2022
Q4 | $13K | Buy |
800
+300
| +60% | +$4.88K | ﹤0.01% | 1218 |
|
|
2022
Q3 | $9K | Sell |
500
-1,300
| -72% | -$23.4K | ﹤0.01% | 1404 |
|
|
2022
Q2 | $23K | Sell |
1,800
-1,500
| -45% | -$19.2K | ﹤0.01% | 1149 |
|
|
2022
Q1 | $30K | Sell |
3,300
-1,100
| -25% | -$10K | ﹤0.01% | 1227 |
|
|
2021
Q4 | $42K | Sell |
4,400
-300
| -6% | -$2.86K | ﹤0.01% | 1247 |
|
|
2021
Q3 | $159K | Sell |
4,700
-3,050
| -39% | -$103K | 0.01% | 788 |
|
|
2021
Q2 | $283K | Buy |
7,750
+2,451
| +46% | +$89.5K | 0.01% | 599 |
|
|
2021
Q1 | $237K | Buy |
5,299
+3,600
| +212% | +$161K | 0.01% | 613 |
|
|
2020
Q4 | $96K | Sell |
1,699
-1,100
| -39% | -$62.2K | ﹤0.01% | 805 |
|
|
2020
Q3 | $143K | Sell |
2,799
-900
| -24% | -$46K | 0.01% | 566 |
|
|
2020
Q2 | $220K | Sell |
3,699
-218
| -6% | -$13K | 0.01% | 427 |
|
|
2020
Q1 | $161K | Sell |
3,917
-27,744
| -88% | -$1.14M | 0.01% | 487 |
|
|
2019
Q4 | $1.97M | Buy |
31,661
+31,461
| +15,731% | +$1.96M | 0.12% | 124 |
|
|
2019
Q3 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1265 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2331 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2335 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2306 |
|